Varex Imaging Corporation (VREX) Fair Value 2026

VREX · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.3 /10

32 fundamental signals · 7 models active

Value Trap Risk

LOW (27/100)

Quick Summary — As of 2026-08-27, Varex Imaging Corporation (VREX) trades at $18.49, versus a $13.30 median fair value across its 7 active models — 28.0% below the current price. QOC: 7.3/10. Value Trap Risk: 27/100 (LOW). 7/13 models active.

Key Facts

Ticker
VREX
Price
$18.49
Quality Score
7.3/10
Value Trap Risk
27/100
Models Active
7/13
Last Updated
Strength: 7 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is Varex Imaging Corporation (VREX) Undervalued or Overvalued in 2026?

According to CirclFi’s 7-model valuation engine, Varex Imaging Corporation (VREX) appears overvalued as of : the median of 7 independent fair value estimates is $13.30, 28.0% below the current price of $18.49. Estimates range from $4.76 to $32.84. VREX scores 7.3/10 on fundamental quality and 27/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. VREX’s -28.0% gap is wider than that market norm, and the Medical Devices sector median is -43.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Varex Imaging Corporation Stock in 2026? →

What Fair Value Does Each Model Give VREX?

7 Intrinsic Value Models vs. Current Price ($18.49)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $4.76 -74.2%
Ensemble · Low Conviction
 $13.30 -28.0%
Intrinsic · High Conviction
 $6.51 -64.8%
Unlock the Full Matrix

Access 4 additional models including PWERM, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 7 Models →

Cancel anytime · No contracts · Instant access

What Is VREX's Fair Value Range?

Spread across 7 independent models · $4.76 to $32.84

CirclFi's 7 active models place Varex Imaging Corporation (VREX) between $4.76 and $32.84 per share, a spread of 211% of the median. The median of that range — $13.30 — is the fair value CirclFi publishes for VREX, against a current price of $18.49.

Low · EPVHigh · Regime Cross
$4.76median $13.30$32.84
Where the range comes from
Most bearish modelEarnings Power Value (EPV)$4.76
Most bullish modelRegime Cross-Sectional$32.84
Model agreement2 bullish · 4 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for VREX. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on VREX, not a CirclFi price target. How each model works →

What Is Varex Imaging Corporation (VREX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Varex Imaging Corporation at its current price of $18.49. The median intrinsic value is estimated at $13.30 (-28.0% vs price), with 4 models flagging overvaluation risk. Notably, Regime Cross sees the most upside at +77.6% (fair value: $32.84), while EPV is the most conservative at -74.2% ($4.76). The spread between these extremes — +151.8% — reveals how different analytical frameworks can reach starkly different conclusions. Among models with highest confidence, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About VREX?

7 of 13 models are currently active for VREX. Of these, 3 models suggest upside while 4 models suggest overvaluation. Taken together, their median fair value for VREX is $13.30 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does VREX Rank in Medical Devices?

Among 157 Medical Devices stocks, VREX ranks #37 by Quality of Company score. CirclFi's QOC score of 7.3/10 evaluates 32 fundamental signals. A score of 7.3 indicates above-average quality.

See all Most Undervalued Medical Devices Stocks →

As a healthcare company, Varex Imaging Corporation operates in a sector where pipeline depth and stage distribution is a critical driver of valuation. Investors evaluating VREX should weigh these sector-specific dynamics alongside our model-derived fair values.

Is VREX a Value Trap?

CirclFi's Value Trap algorithm assigns VREX a score of 27/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

7 of 13 models are active for Varex Imaging Corporation. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Varex Imaging Corporation's fundamental quality profile registers 7.3/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +151.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every VREX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across VREX's 7 active models, average confidence is 43%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Varex Imaging Corporation Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

SNWVSANUWAVE Health, Inc.QOC 7.4SRTSSensus Healthcare, Inc.QOC 7.3DCTHDelcath Systems, Inc.QOC 7.4SGHTSight Sciences, Inc.QOC 7.3SIBNSI-BONE, Inc.QOC 7.5AORTArtivion, Inc.QOC 7.3APYXApyx Medical CorporationQOC 6.3NUWENuwellis, Inc.QOC 5.3ICCMIceCure Medical LtdQOC 2.8IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: SNWV · SRTS · DCTH · SGHT · SIBN · AORT · APYX · NUWE · ICCM · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to VREX?

7 companies across all industries closest to VREX’s Quality of Company score of 7.3/10.

HGBLHeritage Global Inc.QOC 7.3BNBrookfield CorporationQOC 7.3TITNTitan Machinery Inc.QOC 7.3ORAOrmat Technologies, Inc.QOC 7.3HSICHenry Schein, Inc.QOC 7.3LNTAlliant Energy CorporationQOC 7.3NVDANVIDIA CorporationQOC 10.0

Read investment analysis: HGBL · BN · TITN · ORA · HSIC · LNT · NVDA

Where Does VREX Sit in CirclFi's Medical Devices Rankings?

VREX is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Varex Imaging Corporation’s Valuation?

What is Varex Imaging Corporation's intrinsic value in 2026?

CirclFi puts Varex Imaging Corporation (VREX)'s intrinsic value at $13.30 — the median of 7 independent model estimates as of 2026-08-27, ranging from $4.76 to $32.84. The Quality of Company score is 7.3/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is VREX overvalued or undervalued right now?

At $18.49, 3 of 7 active models suggest VREX may be undervalued, while 4 indicate potential overvaluation. The median of all 7 fair value estimates is $13.30, 28.0% below the current price of $18.49 — a consensus view that VREX is overvalued. The assessment depends on which methodology best fits Varex Imaging Corporation's business model in Medical Devices.

What does a Quality of Company score of 7.3 mean for VREX?

Varex Imaging Corporation's QOC of 7.3/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on VREX?

CirclFi analyzes VREX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 7 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on VREX?

Of the 7 models currently active on VREX, Regime Cross-Sectional is the most bullish at $32.84 per share, and Earnings Power Value (EPV) is the most bearish at $4.76. CirclFi's published fair value for VREX is the median of that range, $13.30, not either extreme. The gap between the two ends equals 211% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is VREX a value trap in 2026?

Varex Imaging Corporation's Value Trap score is 27/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 7-model valuation engine, Varex Imaging Corporation (VREX) has a median fair value of $13.30 — 28.0% below the current price of $18.49 — as of 2026-08-27.” Source: circlfi.com/stock/VREX/ · Methodology
Primary sources for this VREX valuation
  • Financial statements: Varex Imaging Corporation 10-K and 10-Q filings on SEC EDGAR (CIK 0001681622) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for VREX as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 7 mathematical frameworks give you clarity on VREX.

Unlock All 7 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

4 models hidden for VREX Unlock All 7 — $39/mo